Contrarian take on AlphaGenome 2 release as a signal that the highest-leverage builder opportunities in 2027-2028 are in biology and science, not software productivity
The Builder Opportunity Nobody Is Talking About Most builders in the AI space right now are optimizing for the wrong signal. They’re watching token prices drop, reasoning benchmarks climb, and coding assistants ship faster. That’s real progress. But I think 2027 and 2028 belong to something else entirely, and AlphaGenome 2 is the clearest evidence…
